company background image
KOTR

Kotra Industries Berhad KLSE:KOTRA Stock Report

Last Price

RM4.09

Market Cap

RM605.2m

7D

-2.6%

1Y

81.0%

Updated

14 Aug, 2022

Data

Company Financials
KOTRA fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance6/6
Financial Health6/6
Dividends3/6

KOTRA Stock Overview

Kotra Industries Berhad, an investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia.

Kotra Industries Berhad Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kotra Industries Berhad
Historical stock prices
Current Share PriceRM4.09
52 Week HighRM4.64
52 Week LowRM2.26
Beta0.0081
1 Month Change3.54%
3 Month Change1.74%
1 Year Change80.97%
3 Year Change128.49%
5 Year Change110.82%
Change since IPO818.18%

Recent News & Updates

Shareholder Returns

KOTRAMY PharmaceuticalsMY Market
7D-2.6%-0.2%0.2%
1Y81.0%-3.9%-3.5%

Return vs Industry: KOTRA exceeded the MY Pharmaceuticals industry which returned -3.9% over the past year.

Return vs Market: KOTRA exceeded the MY Market which returned -3.5% over the past year.

Price Volatility

Is KOTRA's price volatile compared to industry and market?
KOTRA volatility
KOTRA Average Weekly Movement3.2%
Pharmaceuticals Industry Average Movement3.9%
Market Average Movement5.5%
10% most volatile stocks in MY Market11.7%
10% least volatile stocks in MY Market2.7%

Stable Share Price: KOTRA is less volatile than 75% of MY stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: KOTRA's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1982664Jimmy Pionghttps://kotrapharma.com

Kotra Industries Berhad, an investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia. The company provides nutraceutical products, including various health supplement products under the Appeton brand for children, expectant mothers, and seniors. It also offers various pharmaceutical products in the areas of pediatric care, anti-infective, gastroenterology, and dermatology in various dosage forms, such as tablets, capsules, creams, and ointments under the Axcel brand; and sterile antibiotic injectables under the Vaxcel brand.

Kotra Industries Berhad Fundamentals Summary

How do Kotra Industries Berhad's earnings and revenue compare to its market cap?
KOTRA fundamental statistics
Market CapRM605.22m
Earnings (TTM)RM58.30m
Revenue (TTM)RM202.63m

10.4x

P/E Ratio

3.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
KOTRA income statement (TTM)
RevenueRM202.63m
Cost of RevenueRM50.96m
Gross ProfitRM151.66m
Other ExpensesRM93.36m
EarningsRM58.30m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.39
Gross Margin74.85%
Net Profit Margin28.77%
Debt/Equity Ratio4.0%

How did KOTRA perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

42%

Payout Ratio